[go: up one dir, main page]

MEP91508A - Method for preparing combretastatins - Google Patents

Method for preparing combretastatins

Info

Publication number
MEP91508A
MEP91508A MEP-915/08A MEP91508A MEP91508A ME P91508 A MEP91508 A ME P91508A ME P91508 A MEP91508 A ME P91508A ME P91508 A MEP91508 A ME P91508A
Authority
ME
Montenegro
Prior art keywords
combretastatins
preparing
group
phosphonium salt
vititi
Prior art date
Application number
MEP-915/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Stephane Mutti
Michel Lavigne
Irina Malejonock
Jean-Paul Casimir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of MEP91508A publication Critical patent/MEP91508A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Magnetic Ceramics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
MEP-915/08A 2002-04-11 2003-04-09 Method for preparing combretastatins MEP91508A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0204499A FR2838437B1 (fr) 2002-04-11 2002-04-11 Procedes de preparation de combretastatines
PCT/FR2003/001117 WO2003084919A2 (fr) 2002-04-11 2003-04-09 Procedes de preparation de combretastatines

Publications (1)

Publication Number Publication Date
MEP91508A true MEP91508A (en) 2011-12-20

Family

ID=28459732

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-915/08A MEP91508A (en) 2002-04-11 2003-04-09 Method for preparing combretastatins

Country Status (28)

Country Link
EP (3) EP1497255A2 (xx)
JP (1) JP4299677B2 (xx)
KR (1) KR101018983B1 (xx)
CN (1) CN1291970C (xx)
AR (2) AR039198A1 (xx)
AU (1) AU2003260026B2 (xx)
BR (1) BR0309087A (xx)
CA (1) CA2481742C (xx)
CR (1) CR7481A (xx)
EA (1) EA007965B1 (xx)
EC (1) ECSP045348A (xx)
FR (1) FR2838437B1 (xx)
HK (1) HK1075651A1 (xx)
HR (1) HRP20040935A2 (xx)
IL (1) IL164247A0 (xx)
MA (1) MA26407A1 (xx)
ME (1) MEP91508A (xx)
MX (1) MXPA04009112A (xx)
NO (2) NO329701B1 (xx)
NZ (1) NZ535318A (xx)
OA (1) OA12804A (xx)
PL (3) PL213967B1 (xx)
RS (3) RS52331B (xx)
TN (1) TNSN04201A1 (xx)
TW (1) TWI262179B (xx)
UA (1) UA76079C2 (xx)
WO (1) WO2003084919A2 (xx)
ZA (1) ZA200407417B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7235688B1 (en) 2004-11-04 2007-06-26 University Of Notre Dame Du Lac Process for preparing histone deacetylase inhibitors and intermediates thereof
FR2928148B1 (fr) * 2008-02-28 2013-01-18 Sanofi Aventis Procede de preparation de combretastatine
FR2939665B1 (fr) 2008-12-12 2011-10-07 Sanofi Aventis Combinaison antitumorale associant l'ave8062a et le docetaxel
FR2945210B1 (fr) 2009-05-07 2011-07-01 Sanofi Aventis Combinaison antitumorale comprenant l'ave8062 et le sorafenib
FR2953518B1 (fr) * 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
EP2481404A1 (en) 2010-11-15 2012-08-01 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2397135A1 (en) 2010-06-18 2011-12-21 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
WO2011158206A1 (en) 2010-06-18 2011-12-22 Sanofi An antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative
EP2407161A1 (en) 2010-07-13 2012-01-18 Sanofi An antitumoral combination comprising ombrabulin and bevacizumab
FR2968557A1 (fr) 2010-12-09 2012-06-15 Sanofi Aventis Combinaison antitumorale comprenant un derive de la famille des combretastatines et le cetuximab
FR2978662A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cisplatine, associee a la radiotherapie
FR2978663A1 (fr) 2011-08-01 2013-02-08 Sanofi Sa Combinaison antitumorale comprenant l'ombrabuline et le cetuximab, associee a la radiotherapie
CN103012248B (zh) * 2013-01-11 2014-11-05 浙江大德药业集团有限公司 氨基康普立停衍生物的合成及其作为口服抗肿瘤药物的应用
EP3184095A1 (en) 2013-05-23 2017-06-28 IP Gesellschaft für Management mbH Administration units comprising polymorph 1 of 2-(2-methylamino-pyrimidin-4-yl]-1h-indole-5-carboxylic acid [(s)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide
EP4079327A1 (en) 2021-04-22 2022-10-26 Centaurus Polytherapeutics Payloads for drug-conjugates and their use for treating cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996237A (en) 1987-01-06 1991-02-26 Arizona Board Of Regents Combretastatin A-4
UA19045A (uk) * 1988-02-24 1997-12-25 Ф.Хофманн - Ля Рош Аг Спосіб одержаhhя похідhих стильбеhу
NZ232897A (en) * 1989-04-03 1992-12-23 Squibb & Sons Inc Interphenylene 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogues, preparation and pharmaceutical compositions thereof
US5731353A (en) * 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
CA2187214C (en) * 1994-04-06 2002-03-12 Hiroyoshi Hidaka Aminostilbazole derivative and medicine
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JP4551514B2 (ja) * 1999-07-23 2010-09-29 住友化学株式会社 不飽和炭化水素残基置換アニリン類の製造方法
GB9918912D0 (en) 1999-08-12 1999-10-13 Angiogene Pharm Ltd New stilbenes with vascular damaging activity

Also Published As

Publication number Publication date
JP2005522478A (ja) 2005-07-28
CN1291970C (zh) 2006-12-27
AR082581A2 (es) 2012-12-19
MA26407A1 (fr) 2004-12-01
NO20044814L (no) 2004-01-07
ZA200407417B (en) 2006-04-26
BR0309087A (pt) 2005-02-09
EA007965B1 (ru) 2007-02-27
PL214129B1 (pl) 2013-06-28
FR2838437B1 (fr) 2004-06-04
NO331372B1 (no) 2011-12-12
RS20110561A2 (xx) 2012-10-31
AR039198A1 (es) 2005-02-09
TW200401762A (en) 2004-02-01
CA2481742C (fr) 2012-06-19
AU2003260026A1 (en) 2003-10-20
PL394820A1 (pl) 2011-09-12
MXPA04009112A (es) 2004-12-07
FR2838437A1 (fr) 2003-10-17
RS20110562A2 (xx) 2012-10-31
EP1497255A2 (fr) 2005-01-19
JP4299677B2 (ja) 2009-07-22
IL164247A0 (en) 2005-12-18
UA76079C2 (en) 2006-06-15
RS20110562A3 (xx) 2013-12-31
TWI262179B (en) 2006-09-21
RS86504A (xx) 2007-02-05
CN1646476A (zh) 2005-07-27
KR101018983B1 (ko) 2011-03-07
TNSN04201A1 (fr) 2007-03-12
PL213708B1 (pl) 2013-04-30
CR7481A (es) 2008-11-25
NO329701B1 (no) 2010-12-06
OA12804A (fr) 2006-07-11
WO2003084919A2 (fr) 2003-10-16
RS52331B (en) 2012-12-31
AU2003260026B2 (en) 2008-01-03
PL394821A1 (pl) 2011-09-12
HRP20040935A2 (en) 2005-10-31
RS20110561A3 (xx) 2013-10-31
PL371629A1 (en) 2005-06-27
WO2003084919A3 (fr) 2004-04-08
NO20101215L (no) 2004-01-07
EP2348012A1 (fr) 2011-07-27
KR20040108717A (ko) 2004-12-24
EP2354118A1 (fr) 2011-08-10
EA200401350A1 (ru) 2005-02-24
HK1075651A1 (en) 2005-12-23
ECSP045348A (es) 2004-11-26
PL213967B1 (pl) 2013-05-31
CA2481742A1 (fr) 2003-10-16
NZ535318A (en) 2007-02-23

Similar Documents

Publication Publication Date Title
MEP91508A (en) Method for preparing combretastatins
ATE438638T1 (de) Sulfoniumsalze als photoinitiatoren für strahlungshärtbare systeme
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
DK1487863T3 (da) Fremgangsmåde til oprensning af glycopeptidphosponatderivater
HK1088597A1 (en) Method for the production of substituted 3-aryl-butyl amine compounds
CY1105410T1 (el) Υποκατεστημενες 2-φαινυλοβενζιμιδαζολες, η παρασκευη και η εφαρμογη τους
TW200519089A (en) Biaryl sulfonamides and methods for using same
BR9910332A (pt) Polipeptìdio, composição, método para purificação de polipeptìdio a partir de uma composição e método para purificação de um anticorpo a partir de uma composição
CY1105084T1 (el) Διepγασια για καθαρισμο σωματιδιων που ομοιαζουν με τα σωματιδια ιου θηλωματων
TW200519100A (en) Biaryl sulfonamides and methods for using same
PL379543A1 (pl) Wytwarzanie pochodnych 1,3-difenyloprop-2-en-1-onu
RS20060250A (xx) Derivati tetrahidronaftalena, postupak njihove proizvodnje i njihova upotreba kao anti-inflamatornih sredstava
ITMI20030957A1 (it) Macchina per legatoria per la lavorazione di blocchi di libro, ad elevata precisione di funzionamento.
DK1141368T3 (da) Fremgangsmåde til produktion af ascorbinsyremellemprodukter
ATE291024T1 (de) Neue 4-aminofuropyrimidine und ihre verwendung
UY27606A1 (es) Inhibidores de la fosfarasa
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
DE502005009449D1 (de) Metallreflektor und Verfahren zu dessen Herstellung
ATE508633T1 (de) Eprosartan-zusammensetzungen
EA200200101A1 (ru) Получение замещенных пиперидин-4-онов
ATE253037T1 (de) Verfahren zur racematspaltung von tramadol
DE50115655D1 (de) Verfahren zur herstellung von unsymmetrischen 4,6-bis(aryloxy)pyrimidin-derivaten
DK1080040T3 (da) Fremgangsmåde til oprensning af vand
NO20062647L (no) Fremgangsmate for fremstilling av substituerte aminoalkonoler
HUP0104648A2 (hu) Eljárás polihalogénezett p-trifluorometil-anilinek előállítására